The Trump administration's dynamic and unpredictable trade policy now targets the pharmaceutical sector, threatening significant tariffs. With a proposed 200% tariff looming, the industry faces ...

Since April 2, or “Liberation Day,” as the White House now calls it, Donald Trump has invoked emergency legal powers to ...

Novartis (NYSE:NVS) (SIX:NOVN) said its experimental antibody ianalumab, used in combination with eltrombopag, achieved the ...